Transfer of interferon beta in term placentae
This study provides additional evidence to support the consideration of use of IFN-β based MS medications in pregnancy. The minimal transfer in the term placenta provides reassurance to people with MS and medical professionals considering the use of medication during the third trimester.
Authors
- Ruth Dobson (ORCID: https://orcid.org/0000-0002-2993-585X)
- Paul Brownbill (ORCID: https://orcid.org/0000-0002-8328-7072)
- Angelos Evangelinos (ORCID: https://orcid.org/0000-0002-0226-1445)
- Eleanor A. Doman (ORCID: https://orcid.org/0000-0002-4078-4749)
- Lewis Renshall (ORCID: https://orcid.org/0000-0002-2491-8014)
Institutions
- Queen Mary University of London (GB)
- Manchester Academic Health Science Centre (GB)
Publication Details
- Journal
- Multiple Sclerosis and Related Disorders
- Published
- 2025-12-20
- DOI
- https://doi.org/10.1016/j.msard.2025.106942
- Primary Topic
- Reproductive System and Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Multiple Sclerosis Society